Imedex E-Learning (Video)   /   Psoriasis: Translating Current and Emerging Therapies into Enhanced Management Strategies - Joel M. Gelfand, MD, MSCE

http://itunes.imedex.com/images/itunes/19-ias-203.jpg

Summary

Dr. Joel M. Gelfand reviews the latest data regarding the pathogenesis of psoriasis (PsO) and the contribution of IL-23/Th17 signaling pathways to disease state, and discusses personalized treatment plans for patients with moderate-to-severe PsO that successfully incorporate both current and emerging therapies.

Subtitle
Dr. Joel M. Gelfand reviews the latest data regarding the pathogenesis of psoriasis (PsO) and the contribution of IL-23/Th17 signaling pathways to disease state, and discusses personalized treatment plans for patients with moderate-to-severe PsO that su
Duration
37:31
Publishing date
2019-07-11 19:00
Link
https://example.com
Contributors
HMP CME author  
Enclosures
19-ias-203.mp4